{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:49:47Z","timestamp":1794667787048,"version":"4.9.1"},"reference-count":48,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"unspecified","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82202027"],"award-info":[{"award-number":["82202027"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U22A20328"],"award-info":[{"award-number":["U22A20328"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Science and Technology Plan Project of Fuzhou Health and Health System","award":["2022-S-wt2"],"award-info":[{"award-number":["2022-S-wt2"]}]},{"name":"Scientific Foundation of Fujian Province","award":["2023J06049"],"award-info":[{"award-number":["2023J06049"]}]},{"name":"Fuzhou Science and technology planning project","award":["2023-R-003"],"award-info":[{"award-number":["2023-R-003"]}]},{"name":"The Major Research Projects for Young and Middle-aged Talent of Fujian Provincial Health Commission","award":["2022ZQNZD014"],"award-info":[{"award-number":["2022ZQNZD014"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2024,11,26]]},"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liver metastasis is highly aggressive and immune tolerant, and lacks effective treatment strategies. This study aimed to develop a neoantigen hydrogel vaccine (NPT-gels) with high clinical feasibility and further investigate its efficacy and antitumor molecular mechanisms in combination with immune checkpoint inhibitors (ICIs) for the treatment of liver metastases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The effects of liver metastasis on survival and intratumor T-cell subpopulation infiltration in patients with advanced tumors were investigated using the Surveillance, Epidemiology, and End Results Program (SEER) database and immunofluorescence staining, respectively. NPT-gels were prepared using hyaluronic acid, screened neoantigen peptides, and dual clinical adjuvants [Poly(I:C) and thymosin \u03b1-1]. Then, the efficacy and corresponding antitumor molecular mechanisms of NPT-gels combined with programmed death receptor 1 and cytotoxic T-lymphocyte-associated protein 4 double blockade (PCDB) for the treatment of liver metastases were investigated using various preclinical liver metastasis models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Liver metastases are associated with poorer 5-year overall survival, characterized by low infiltration of cytotoxic CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells and high infiltration of regulatory T cells (Tregs). NPT-gels overcame the challenges faced by conventional neoantigen peptide vaccines by sustaining a durable, high-intensity immune response with a single injection and significantly improving the infiltration of neoantigen-specific T-cell subpopulations in different mice subcutaneous tumor models. Importantly, NPT-gels further combined with PCDB could enhance neoantigen-specific T-cell infiltration and effectively unlock the immunosuppressive microenvironment of liver metastases, showing superior antitumor efficacy and inducing long-term immune memory in various preclinical liver metastasis models without obvious toxicity. Mechanistically, the combined strategy can inhibit Tregs, induce the production and infiltration of neoantigen-specific CD8\n                      <jats:sup>+<\/jats:sup>\n                      CD69\n                      <jats:sup>+<\/jats:sup>\n                      T cells to enhance the immune response, and potentially elicit antigen-presenting effects in Na\u00efve B_Ighd\n                      <jats:sup>+<\/jats:sup>\n                      cells and M1-type macrophages.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study demonstrated that NPT-gels combined with PCDB could exert a durable and powerful antitumor immunity by enhancing the recruitment and activation of CD8\n                      <jats:sup>+<\/jats:sup>\n                      CD69\n                      <jats:sup>+<\/jats:sup>\n                      T cells, which supports the rationale and clinical translation of this combination strategy and provides important evidence for further improving the immunotherapy efficacy of liver metastases in the future.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2024-009543","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T10:20:49Z","timestamp":1734517249000},"page":"e009543","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Personalized neoantigen hydrogel vaccine combined with PD-1 and CTLA-4 double blockade elicits antitumor response in liver metastases by activating intratumoral CD8\n                    <sup>+<\/sup>\n                    CD69\n                    <sup>+<\/sup>\n                    T cells"],"prefix":"10.1136","volume":"12","author":[{"given":"Shichuan","family":"Tang","sequence":"first","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"},{"name":"The First Clinical Medical College of Fujian Medical University, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijing","family":"Tang","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"},{"name":"The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Chen","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"},{"name":"The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Zhang","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"},{"name":"The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongying","family":"Lin","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"},{"name":"The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fu","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"},{"name":"The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Guo","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzhou","family":"Lin","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqing","family":"Dong","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"},{"name":"The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingfeng","family":"Huang","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"},{"name":"The First Clinical Medical College of Fujian Medical University, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary, Heze Municipal Hospital, Heze, Shandong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shanxian Central Hospital, Heze, Shandong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Pathology, Heze Municipal Hospital, Heze, Shandong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhu","family":"Lin","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wu","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"},{"name":"The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-4981","authenticated-orcid":false,"given":"Xiaolong","family":"Liu","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"},{"name":"The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyi","family":"Zeng","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"},{"name":"The First Clinical Medical College of Fujian Medical University, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"},{"name":"The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0912-8372","authenticated-orcid":false,"given":"Zhixiong","family":"Cai","sequence":"additional","affiliation":[{"name":"The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China"},{"name":"The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, Fujian, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"2025100309375785000_12.12.e009543.1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203543"},{"key":"2025100309375785000_12.12.e009543.2","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-13-36","article-title":"Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer","volume":"13","author":"Riihim\u00e4ki","year":"2013","journal-title":"BMC Cancer"},{"key":"2025100309375785000_12.12.e009543.3","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198405000-00002"},{"key":"2025100309375785000_12.12.e009543.4","first-page":"5590","article-title":"Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study","volume":"17","author":"Xu","year":"2019","journal-title":"Oncol Lett"},{"key":"2025100309375785000_12.12.e009543.5","first-page":"1135","article-title":"A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient\/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer","volume":"52","author":"Kim","year":"2020","journal-title":"Cancer Res Treat"},{"key":"2025100309375785000_12.12.e009543.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00174"},{"key":"2025100309375785000_12.12.e009543.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31046-2"},{"key":"2025100309375785000_12.12.e009543.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1131-x"},{"key":"2025100309375785000_12.12.e009543.9","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0325"},{"key":"2025100309375785000_12.12.e009543.10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/sciimmunol.aba0759","article-title":"Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis","volume":"5","author":"Lee","year":"2020","journal-title":"Sci Immunol"},{"key":"2025100309375785000_12.12.e009543.11","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"2025100309375785000_12.12.e009543.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.018"},{"key":"2025100309375785000_12.12.e009543.13","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.4564","article-title":"Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial","volume":"6","author":"Yau","year":"2020","journal-title":"JAMA Oncol"},{"key":"2025100309375785000_12.12.e009543.14","doi-asserted-by":"publisher","DOI":"10.1159\/000523702"},{"key":"2025100309375785000_12.12.e009543.15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32522"},{"key":"2025100309375785000_12.12.e009543.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00387-y"},{"key":"2025100309375785000_12.12.e009543.17","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004389","article-title":"Personalized neoantigen vaccine combined with PD-1 blockade increases CD8+ tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models","volume":"10","author":"Chen","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2025100309375785000_12.12.e009543.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-021-01467-8","article-title":"Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion","volume":"20","author":"Cai","year":"2021","journal-title":"Mol Cancer"},{"key":"2025100309375785000_12.12.e009543.19","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00830-x","article-title":"Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity","volume":"6","author":"Cao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2025100309375785000_12.12.e009543.20","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.ijbiomac.2019.11.066","article-title":"Hyaluronic acid: A review on its biology, aspects of drug delivery, route of administrations and a special emphasis on its approved marketed products and recent clinical studies","volume":"151","author":"Vasvani","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"2025100309375785000_12.12.e009543.21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14205163","article-title":"Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments","volume":"14","author":"Niemi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025100309375785000_12.12.e009543.22","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1517\/14712598.2015.1019460","article-title":"Dual effect of Thymosin \u03b1 1 on human monocyte-derived dendritic cell in vitro stimulated with viral and bacterial toll-like receptor agonists","volume":"15 Suppl 1","author":"Giacomini","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"2025100309375785000_12.12.e009543.23","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-023-03598-x","article-title":"Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer","volume":"73","author":"Lin","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"2025100309375785000_12.12.e009543.24","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.1c04977"},{"key":"2025100309375785000_12.12.e009543.25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci Transl Med"},{"key":"2025100309375785000_12.12.e009543.26","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers (Basel)"},{"key":"2025100309375785000_12.12.e009543.27","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060"},{"key":"2025100309375785000_12.12.e009543.28","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10290"},{"key":"2025100309375785000_12.12.e009543.29","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.7150\/ijbs.70524","article-title":"LAMC1-mediated preadipocytes differentiation promoted peritoneum pre-metastatic niche formation and gastric cancer metastasis","volume":"18","author":"Fang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"2025100309375785000_12.12.e009543.30","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-01107-7","article-title":"p53 positively regulates the proliferation of hepatic progenitor cells promoted by laminin-521","volume":"7","author":"Ma","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2025100309375785000_12.12.e009543.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1612717113"},{"key":"2025100309375785000_12.12.e009543.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0306"},{"key":"2025100309375785000_12.12.e009543.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.08.001"},{"key":"2025100309375785000_12.12.e009543.34","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s43018-022-00456-0","article-title":"Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect","volume":"3","author":"Nishiga","year":"2022","journal-title":"Nat Cancer"},{"key":"2025100309375785000_12.12.e009543.35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-019-1836-5","article-title":"An intra-tumoral niche maintains and differentiates stem-like CD8 T cells","volume":"576","author":"Jansen","year":"2019","journal-title":"Nature New Biol"},{"key":"2025100309375785000_12.12.e009543.36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/cancers14174333","article-title":"The Efficacy of PD-1\/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study","volume":"14","author":"Xie","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025100309375785000_12.12.e009543.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.09.038"},{"key":"2025100309375785000_12.12.e009543.38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature New Biol"},{"key":"2025100309375785000_12.12.e009543.39","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13025","article-title":"Peptide-based therapeutic cancer vaccine: Current trends in clinical application","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif"},{"key":"2025100309375785000_12.12.e009543.40","first-page":"3924","article-title":"Supramolecular co-assembly of self-adjuvanting nanofibrious peptide hydrogel enhances cancer vaccination by activating MyD88-dependent NF-\u03baB signaling pathway without inflammation","volume":"6","author":"Su","year":"2021","journal-title":"Bioact Mater"},{"key":"2025100309375785000_12.12.e009543.41","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1021\/acscentsci.0c00732","article-title":"Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral Immunity","volume":"6","author":"Roth","year":"2020","journal-title":"ACS Cent Sci"},{"key":"2025100309375785000_12.12.e009543.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.01.004"},{"key":"2025100309375785000_12.12.e009543.43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/biomedicines10102454","article-title":"The Abundance of Tumor-Infiltrating CD8+ Tissue Resident Memory T Lymphocytes Correlates with Patient Survival in Glioblastoma","volume":"10","author":"La Manna","year":"2022","journal-title":"Biomedicines"},{"key":"2025100309375785000_12.12.e009543.44","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1877"},{"key":"2025100309375785000_12.12.e009543.45","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0333-y"},{"key":"2025100309375785000_12.12.e009543.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.08.027"},{"key":"2025100309375785000_12.12.e009543.47","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0075"},{"key":"2025100309375785000_12.12.e009543.48","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0462-y"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2024-009543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:38:12Z","timestamp":1759509492000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2024-009543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,18]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/jitc-2024-009543"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2024-009543","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}